Physician profile
Matthew Goldman
NPI 1417166166
$1,599.19
in general payments reported to CMS, 2019-2025
14 companies · $418 in 2025
The $418 reported for 2025 was more than what 76% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $459 · 2020: $127 · 2021: $321 · 2022: $74.22 · 2023: $15.31 · 2024: $186 · 2025: $418.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $618.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $618.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $493.53 | 2020-2025 | Dynatape, Truespan Orthocord, Dynacord |
| Smith+Nephew, INC. | $389.31 | 2019-2025 | Intellio Link Werewolf, Evos |
| Zimmer Biomet Holdings, INC. | $142.31 | 2019-2024 | Tapestry |
| Pacira Therapeutics, INC. | $125.00 | 2019-2021 | |
| Bioventus LLC | $112.80 | 2019-2025 | Durolane |
| Ferring Pharmaceuticals INC. | $105.66 | 2019-2025 | Euflexxa |
| Orthalign INC | $74.66 | 2025 | Orthalign Plus |
| Heraeus Medical, LLC. | $38.03 | 2022 | |
| Baxter Healthcare | $28.58 | 2024 | Floseal |
| Vertex Pharmaceuticals Incorporated | $24.60 | 2025 | |
| Becton, Dickinson and Company | $20.40 | 2024 | Arista Ah Flexitip |
| Medtronic, INC. | $16.25 | 2024 | Intellis Adaptivestim |
| Sanofi-Aventis U.S. LLC | $14.61 | 2019 | |
| Medical Device Business Services, INC. | $13.45 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Goldman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.